A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories


May 29, 2007
Lipid Problems Explored in Women
(Reuters Health) Untreated HIV-infected women have lower levels of high-density lipoprotein cholesterol (HDL-C) and higher triglyceride levels compared with uninfected women, according to data from the Women's Interagency HIV Study. This pattern is aggravated by treatment that includes protease inhibitors.
May 25, 2007
'Serosorting' Risk can be High
(AIDSmeds.com) A new mathematical model study suggests that, in some circumstances, serosorting may be associated with a higher risk of HIV infection, largely due to recently infected individuals still thinking and disclosing that they are seronegative.
May 23, 2007
Some Do Well After Treatment Interruption
(Reuters Health) Treatment interruption appears safe in a subgroup of HIV patients with preserved immune function, researchers report in the May 15th issue of the Journal of Infectious Diseases.
May 22, 2007
'Runaway' Theory Doesn't Explain Slow CD4 Loss
(AIDSmeds.com) A new study refutes a longstanding theory of how HIV slowly depletes the body's capacity to fight infection.
May 18, 2007
HIV Vaccines May Work in Unexpected Ways
(AIDSmeds.com) Even if current top HIV vaccine candidates do not prevent infection, they may still prove beneficial by prolonging disease-free survival and reducing secondary viral transmission.
Accurate Immune System Marker in Poor Countries
(Reuters Health) A new algorithm based on components of a complete blood cell count (CBC) gives a better estimate of CD4 cell count in HIV patients than estimates using the total lymphocyte count (TLC).
May 17, 2007
Regular Healthcare Visits a Key to Survival
(AIDSmeds.com) HIV-positive people who do not consult with their healthcare providers on a regular basis do not live as long as those who do, according to a new study.
Spinal Chemicals May Predict HIV Dementia Risk
(Reuters Health) Various biomarkers indicate risk for development of HIV-associated dementia and for worsening of the condition, according to a report in the May 1st issue of Neurology.
May 16, 2007
Pubic Lipomas a Lipo Symptom?
(Reuters Health) A distinctive suprapubic fat pad is often present in patients with HIV-associated lipodystrophy, but it is often overlooked, Italian researchers report in the May 1st issue of the Journal of Acquired Immune Deficiency Syndrome.
May 15, 2007
Study Finds Abacavir Allergy Screening Useful
(Reuters Health) Hypersensitivity to abacavir can be detected by screening for HLA-B*5701 and is recommended for HIV-infected individuals who are candidates for the antiviral agent, French researchers report.
May 14, 2007
Kaletra Regimens 'Forgiving' of Missed Doses
(Reuters Health) Adherence rates to lopinavir/ritonavir regimens that fall below 95% can still bring about high rates of virologic suppression in HIV infection, according to a new study.
May 11, 2007
No Drop in Non-AIDS Cancer Rates
(Reuters Health) The effect of highly active antiretroviral therapy (HAART) on the incidence of non-AIDS-defining cancers in adults with AIDS is variable, with little effect seen in many instances, according to a report in the May 15th American Journal of Epidemiology.
May 10, 2007
PIs and Non-Nukes Cause Similar Metabolic Problems
(Reuters Health) The long-term metabolic consequences of antiretroviral therapy (ART) are similar with protease inhibitors (PI), nonnucleoside reverse transcriptase inhibitors (NNRTI), or the combination thereof, according to a report in the April 15th issue of the Journal of Acquired Immune Deficiency Syndromes.
May 08, 2007
Glitazones Not Likely Useful for Lipoatrophy
(AIDSmeds.com) A Toronto-based study has concluded that “glitazones” don't offer any significant benefit compared to placebo in terms of reversing HIV-associated lipoatrophy.
Study Explores Lipid Problems in Women
(AIDSmeds.com) New data indicate that lipid problems can vary, depending on a woman’s HIV status, whether or not she’s on HIV treatment, or which antiretrovirals she is using.
Hysterectomy Rates Higher in Women with HIV
(Reuters Health) Compared to seronegative at-risk women, those with HIV are more likely to undergo hysterectomy over a 5-year period. However, after adjustment, the difference does not reach significance.
May 04, 2007
Uncommon Causes of Stroke More Frequent in HIV
(Reuters Health) Atypical mechanisms of ischemic stroke are more common in HIV-infected patients than in the general population, according to a report in the April 17th issue of Neurology.
Green Tea for HIV Dementia
(Reuters Health) A compound derived from green tea greatly diminished the neurotoxicity of proteins secreted by HIV in a study involving mice suggesting a new approach to prevent and treat HIV-associated dementia.
May 03, 2007
HIV Treatment Good for Growth in Kids
(Reuters Health) HIV-infected children treated with highly active antiretroviral therapy (HAART) experience significant catch-up in height and weight, according to a report in the April issue of The Pediatric Infectious Disease Journal.
May 02, 2007
Race, Mental Health Affect HIV Treatment
(Reuters Health) Race and psychiatric disorders influence the risk of highly active antiretroviral therapy (HAART) failure, according to a report by researchers at Walter Reed Army Naval Medical Center, Washington, DC.
HAART to Heart: It’s Not Just the Meds
HIV and antiretroviral treatment are not hurting your heart any more than a doughnut addiction or that pack of cigarettes in your pocket. 
Possible Lipo Drug Dropkicks Glucose
(AIDSmeds.com) A drug currently being studied as a lipodystrophy treatment may have an advantage of other compounds in development ? an ability to reduce blood glucose levels, a common problem in people with lipodystrophy.
May 01, 2007
PRO 140 Has Potent and Lasting HIV Effect
(AIDSmeds.com) Progenics Pharmaceuticals has announced encouraging results from an early study of PRO 140, its experimental HIV entry inhibitor.
Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
 
Archive

February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    FierceLittleGuy
    WEST HOLLYWOOD
    California


    Savannahman78
    Topeka
    Kansas


    Tuffie
    Washington DC
    DC


    jonhart48
    Stamford
    Connecticut
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.